Jamjoom Pharmaceuticals Factory Company (TADAWUL: 4015)

Jamjoom Pharmaceuticals Factory Company Statistics

Total Valuation

Jamjoom Pharmaceuticals Factory Company has a market cap or net worth of SAR 12.82 billion. The enterprise value is 12.66 billion.

Market Cap	12.82B
Enterprise Value	12.66B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	Aug 18, 2024

Share Statistics

Jamjoom Pharmaceuticals Factory Company has 70.00 million shares outstanding.

Shares Outstanding	70.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	70.07%
Owned by Institutions (%)	0.81%
Float	20.95M

Valuation Ratios

The trailing PE ratio is 38.67 and the forward PE ratio is 32.00. Jamjoom Pharmaceuticals Factory Company's PEG ratio is 2.00.

PE Ratio	38.67
Forward PE	32.00
PS Ratio	10.40
PB Ratio	8.76
P/FCF Ratio	63.73
PEG Ratio	2.00

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.69, with an EV/FCF ratio of 62.94.

EV / Earnings	38.19
EV / Sales	10.27
EV / EBITDA	31.69
EV / EBIT	34.34
EV / FCF	62.94

Financial Position

The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.15.

Current Ratio	3.94
Quick Ratio	2.88
Debt / Equity	0.15
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	3,372.23

Financial Efficiency

Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 15.95%.

Return on Equity (ROE)	23.54%
Return on Assets (ROA)	13.11%
Return on Capital (ROIC)	15.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.72
Inventory Turnover	2.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.84%
50-Day Moving Average	161.86
200-Day Moving Average	139.20
Relative Strength Index (RSI)	60.49
Average Volume (20 Days)	332,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jamjoom Pharmaceuticals Factory Company had revenue of SAR 1.23 billion and earned 331.65 million in profits. Earnings per share was 4.74.

Revenue	1.23B
Gross Profit	771.62M
Operating Income	360.26M
Pretax Income	353.89M
Net Income	331.65M
EBITDA	390.81M
EBIT	360.26M
Earnings Per Share (EPS)	4.74

Balance Sheet

The company has 161.31 million in cash and 2.13 million in debt, giving a net cash position of 159.17 million or 2.27 per share.

Cash & Cash Equivalents	161.31M
Total Debt	2.13M
Net Cash	159.17M
Net Cash Per Share	2.27
Equity (Book Value)	1.46B
Book Value Per Share	20.90
Working Capital	807.92M

Cash Flow

In the last 12 months, operating cash flow was 263.63 million and capital expenditures -62.42 million, giving a free cash flow of 201.22 million.

Operating Cash Flow	263.63M
Capital Expenditures	-62.42M
Free Cash Flow	201.22M
FCF Per Share	2.87

Margins

Gross margin is 62.59%, with operating and profit margins of 29.22% and 26.90%.

Gross Margin	62.59%
Operating Margin	29.22%
Pretax Margin	28.71%
Profit Margin	26.90%
EBITDA Margin	31.70%
EBIT Margin	29.22%
FCF Margin	16.32%

Dividends & Yields

This stock pays an annual dividend of 3.20, which amounts to a dividend yield of 1.75%.

Dividend Per Share	3.20
Dividend Yield	1.75%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	52.77%
Buyback Yield	n/a
Shareholder Yield	1.75%
Earnings Yield	2.59%
FCF Yield	1.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a